Close cervical cancer gap in India, focus on prevention, equity

📌 Summary:

• Context: A modelling study in The Lancet estimates India can prevent more than 10 million cervical cancer cases over the next century if it meets WHO targets — 90% of girls vaccinated against HPV by age 15, 70% of women screened at ages 30+, and 90% of patients treated
• Core argument: The opportunity is extraordinary but so is the challenge — India carries one of the world's heaviest cervical cancer burdens, with over 1.2 lakh new cases and roughly 80,000 deaths each year, and the disease disproportionately punishes the vulnerable
• Causal chain — why the gap persists: (a) the HPV vaccine, introduced in India in 2008, saw limited uptake due to safety concerns, patchy information, logistical gaps and sociocultural barriers; (b) a national HPV vaccination programme for adolescent girls was launched only in February this year, with uneven participation; (c) screening rates are very low — only ~2% of eligible women undergo regular testing
• Key data: cervical cancer is among the most preventable cancers; screening disparities are stark — Tamil Nadu has crossed 10% screening, while Assam and West Bengal are as low as 0.2%
• India's position: India is now among a handful of countries including the HPV vaccine in their national immunisation programme
• Solutions proposed: integrate HPV nucleic acid testing into the National Essential Diagnostics List to expand reach and accuracy of screening beyond urban centres, and use targeted outreach to narrow inequity — a rare chance to cut one of India's most preventable cancer burdens

🎯 UPSC Relevance: GS2 — public health policy, immunisation and disease prevention; health equity across states and social groups; the role of national programmes (universal immunisation, essential diagnostics) in tackling preventable diseases.

📝 Prelims Facts:

• The HPV vaccine was first introduced in India in 2008; a national programme for adolescent girls was launched in February 2026
• India records over 1.2 lakh new cervical cancer cases and around 80,000 deaths annually
• Only about 2% of eligible women in India undergo regular cervical cancer screening
• WHO targets: 90% HPV vaccination by age 15, 70% screening at 30+, 90% treatment

🔑 Key Term: HPV vaccine — a vaccine against the Human Papillomavirus, the main cause of cervical cancer; included in India's national immunisation programme for adolescent girls.